newsfilter
← Latest News
Business Wire·

Cybin Selects Alcohol Use Disorder Indication for Psychedelic Molecule CYB003

Cybin Inc. (NEO:CYBN) (OTCQB:CLXPF) ("Cybin" or the "Company"), a biotechnology company focused on progressing psychedelic therapeutics, today announced that it has selected Alcohol Use Disorder ("AUD") as the initial target indication for its proprieta